Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Cyclophosphamide, Doxorubicin and Etoposide Compared to Carboplatin and Taxol in Patients With Extensive Disease Small Cell Lung Cancer

NCT00003696 is registered in ClinicalTrials.gov with Commissie Voor Klinisch Toegepast Onderzoek as lead sponsor.

NCT NCT00003696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Cyclophosphamide, Doxorubicin and Etoposide Compared to Carboplatin and Taxol in Patients With Extensive Disease Small Cell Lung Cancer
Lead sponsor
Commissie Voor Klinisch Toegepast Onderzoek
Phase
Phase 3
Overall status
Unknown status
Start date
October 31, 1998
Completion date
Not reported
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer